APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
Rita Wilson Dib(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Ray Hachem(The University of Texas MD Anderson Cancer Center), Anne-Marie P. Chaftari(The University of Texas MD Anderson Cancer Center)
Cited by 7
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant <i>Staphylococcus</i> Bacteremic Isolates Embedded in Biofilm
|Antimicrobial Agents and Chemotherapy|2007|347